GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Omni Bio Pharmaceutical Inc (GREY:OMBP) » Definitions » Pretax Margin %

Omni Bio Pharmaceutical (Omni Bio Pharmaceutical) Pretax Margin % : % (As of Dec. 2014)


View and export this data going back to 2007. Start your Free Trial

What is Omni Bio Pharmaceutical Pretax Margin %?

Pre-Tax margin is calculated as Pre-Tax Income divided by its Revenue. Omni Bio Pharmaceutical's Pre-Tax Income for the three months ended in Dec. 2014 was $-1.40 Mil. Omni Bio Pharmaceutical's Revenue for the three months ended in Dec. 2014 was $0.00 Mil. Therefore, Omni Bio Pharmaceutical's pretax margin for the quarter that ended in Dec. 2014 was %.

The historical rank and industry rank for Omni Bio Pharmaceutical's Pretax Margin % or its related term are showing as below:


OMBP's Pretax Margin % is not ranked *
in the Biotechnology industry.
Industry Median: -155.67
* Ranked among companies with meaningful Pretax Margin % only.

Omni Bio Pharmaceutical Pretax Margin % Historical Data

The historical data trend for Omni Bio Pharmaceutical's Pretax Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Omni Bio Pharmaceutical Pretax Margin % Chart

Omni Bio Pharmaceutical Annual Data
Trend Dec06 Dec07 Dec08 Mar09 Mar10 Mar11 Mar12 Mar13 Mar14
Pretax Margin %
Get a 7-Day Free Trial Premium Member Only - - - - -

Omni Bio Pharmaceutical Quarterly Data
Mar10 Jun10 Sep10 Dec10 Mar11 Jun11 Sep11 Dec11 Mar12 Jun12 Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14
Pretax Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Omni Bio Pharmaceutical's Pretax Margin %

For the Biotechnology subindustry, Omni Bio Pharmaceutical's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Omni Bio Pharmaceutical's Pretax Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Omni Bio Pharmaceutical's Pretax Margin % distribution charts can be found below:

* The bar in red indicates where Omni Bio Pharmaceutical's Pretax Margin % falls into.



Omni Bio Pharmaceutical Pretax Margin % Calculation

Pretax margin - also known as pretax profit margin is the ratio of Pretax Income divided by net sales or Revenue, usually presented in percent.

Omni Bio Pharmaceutical's Pretax Margin for the fiscal year that ended in Mar. 2014 is calculated as

Pretax Margin=Pre-Tax Income (A: Mar. 2014 )/Revenue (A: Mar. 2014 )
=-2.517/0
= %

Omni Bio Pharmaceutical's Pretax Margin for the quarter that ended in Dec. 2014 is calculated as

Pretax Margin=Pre-Tax Income (Q: Dec. 2014 )/Revenue (Q: Dec. 2014 )
=-1.399/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Omni Bio Pharmaceutical  (GREY:OMBP) Pretax Margin % Explanation

The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.

The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.

It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.

The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.


Omni Bio Pharmaceutical Pretax Margin % Related Terms

Thank you for viewing the detailed overview of Omni Bio Pharmaceutical's Pretax Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Omni Bio Pharmaceutical (Omni Bio Pharmaceutical) Business Description

Traded in Other Exchanges
N/A
Address
5350 South Roslyn, Suite 430, Greenwood Village, CO, USA, 80111
Omni Bio Pharmaceutical Inc is a US-based biopharmaceutical company, which is engaged in the exploration of new methods of use of alpha-1 antitrypsin (AAT). It offers AAT, a naturally occurring protein that is essential for normal liver and lung function and has been purified from human blood to treat patients suffering from emphysema due to AAT-deficiency. Further, it focuses on the research and development efforts of advancing its first recombinant molecule, AAT and an Fc component of immunoglobulin (AAT-Fc 2) into clinical trials. Geographically these activities are functioned through the region of US.

Omni Bio Pharmaceutical (Omni Bio Pharmaceutical) Headlines

No Headlines